Federal Register / Vol. 86, No. 154 / Friday, August 13, 2021 / Notices 44721 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

ATSDR Exposure Investigations (EIs) 

(OMB Control No. 0923–0048, Exp. 04/ 

30/2022)—Extension—Agency for Toxic 

Substances and Disease Registry 

(ATSDR). 

Background and Brief Description 

The Agency for Toxic Substances and 

Disease Registry (ATSDR) is requesting 

a three-year extension of this generic 

clearance to allow the agency to conduct 

exposure investigations (EIs), through 

methods developed by ATSDR. After a 

chemical release or suspected release 

into the environment, EIs are usually 

requested by officials of a state health 

agency, county health department, the 

Environmental Protection Agency 

(EPA), the general public, and/or 

ATSDR staff. EI results are used by 

public health professionals, 

environmental risk managers, and other 

decision makers to determine if current 

conditions warrant intervention 

strategies to minimize or eliminate 

human exposure. 

All of ATSDR’s targeted biological 

assessments (e.g., urine, blood) and 

some of the environmental 

investigations (e.g., air, water, soil, dust, 

or food sampling) involve participants 

to determine whether they are or have 

been exposed to unusual levels of 

pollutants at specific locations (e.g., 

where people live, spend leisure time, 

or anywhere they might come into 

contact with contaminants under 

investigation). 

Questionnaires, appropriate to the 

specific contaminant, are generally 

needed in about half of the EIs (at most, 

approximately 12 per year) to assist in 

interpreting the biological or 

environmental sampling results. ATSDR 

collects contact information (e.g., name, 

address, phone number) to provide the 

participant with their individual results. 

ATSDR also collects information on 

other possible confounding sources of 

chemical(s) exposure such as medicines 

taken, foods eaten, hobbies, jobs, etc. In 

addition, ATSDR asks questions on 

recreational or occupational activities 

that could increase a participant’s 

exposure potential. The information 

collected represents an individual’s 

exposure history. 

The number of questions can vary 

depending on the number of chemicals 

being investigated, the route of exposure 

(e.g., breathing, eating, touching), and 

the number of other sources of the 

chemical(s) (e.g., products used, jobs). 

We use approximately 12–20 questions 

about the pertinent environmental 

exposures per investigation. A question 

bank is available for health assessors to 

use as a basis of questions to be asked 

during the EI, but EI-specific questions 

may be included as appropriate. 

Typically, the number of participants 

in an individual EI ranges from 10 to 

100. Participation is completely 

voluntary, and there are no costs to 

participants other than their time. Based 

on a maximum of 12 EIs per year and 

100 participants each, the estimated 

annualized burden hours are 600. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hr.) 

Total Burden 

(in hr.) 

Exposure Investigation Participants .. Chemical Exposure Questions ......... 1,200 1 30/60 600 

Total ........................................... ........................................................... ........................ ........................ ........................ 600 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–17351 Filed 8–12–21; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0083; NIOSH 278] 

Board of Scientific Counselors, 

National Institute for Occupational 

Safety and Health (BSC, NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following virtual 

meeting of the Board of Scientific 

Counselors, National Institute for 

Occupational Safety and Health (BSC, 

NIOSH). 

DATES: The meeting will be held on 

October 5, 2021, from 10:00 a.m.–3:30 

p.m., EDT. 

Written comments are due by 

September 28, 2021. 

ADDRESSES: This is a virtual meeting. 

You may submit comments, identified 

by Docket No. CDC–2021–0083; 

NIOSH–278 by mail. CDC does not 

accept comments by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Docket number CDC–2021– 

0083; NIOSH–278, c/o Sherri Diana, 

NIOSH Docket Office, National Institute 

for Occupational Safety and Health, 

1090 Tusculum Avenue, MS C–34, 

Cincinnati, Ohio 45226. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. Written public 

comments received by September 28, 

2021 will be provided to the BSC prior 

to the meeting. Docket number CDC– 

2021–0083; NIOSH–278 will close 

September 28, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Emily J.K. Novicki, M.A., M.P.H., 

Executive Secretary, BSC, NIOSH, CDC, 

1600 Clifton Road NE, MS V24–4, 

Atlanta, GA 30329–4027, Telephone 

(404) 498–2581, or email at enovicki@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Secretary, the Assistant 

Secretary for Health, and by delegation 

the Director, Centers for Disease Control 

and Prevention, are authorized under 

Sections 301 and 308 of the Public 

Health Service Act to conduct directly 


jbell on DSKJLSW7X2PROD with NOTICES
44722 Federal Register / Vol. 86, No. 154 / Friday, August 13, 2021 / Notices 

or by grants or contracts, research, 

experiments, and demonstrations 

relating to occupational safety and 

health and to mine health. The Board of 

Scientific Counselors provides guidance 

to the Director, National Institute for 

Occupational Safety and Health on 

research and prevention programs. 

Specifically, the Board provides 

guidance on the Institute’s research 

activities related to developing and 

evaluating hypotheses, systematically 

documenting findings and 

disseminating results. The Board 

evaluates the degree to which the 

activities of the National Institute for 

Occupational Safety and Health: (1) 

Conform to appropriate scientific 

standards, (2) address current, relevant 

needs, and (3) produce intended results. 

Matters To Be Considered: The agenda 

for the meeting addresses progress on 

the NIOSH Evaluation Capacity 

Building Plan; mental health initiative 

for health workers; and National 

Firefighter Registry. An agenda is also 

posted on the NIOSH website (http://

www.cdc.gov/niosh/bsc/). Agenda items 

are subject to change as priorities 

dictate. Meeting Information: It is open 

to the public, limited only by web 

conference lines (500 web conference 

lines are available). Register at the 

NIOSH website http://www.cdc.gov/ 

niosh/bsc/ or call (404–498–2581) no 

later than September 28, 2021. Time 

will be available for public comment. 

Public Participation 

Comments received are part of the 

public record and are subject to public 

disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

CDC does not accept comment by email. 

Oral Public Comment: The public is 

welcome to participate during the 

public comment period, from 1:00 p.m. 

to 1:15 p.m., EDT, September 28, 2021. 

Please note that the public comment 

period ends at the time indicated above. 

Each commenter will be provided up to 

five minutes for comment. A limited 

number of time slots are available and 

will be assigned on a first come-first 

served basis. Members of the public 

who wish to address the NIOSH BSC are 

requested to contact the Executive 

Secretary for scheduling purposes (see 

FOR FURTHER INFORMATION above). 

Written Public Comment: Written 

comments will also be accepted from 

those unable to attend the public 

session per the instructions provided in 

the address section above. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. Written 

comments received by September 28, 

2021 will be provided to the BSC prior 

to the meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–17395 Filed 8–12–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21HD; Docket No. CDC–2021– 

0080] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled One Health SARS–CoV–2 Animal 

Testing Form, which aims to improve 

the scientific community’s 

understanding of the number of animals 

state officials report are tested for 

SARS–CoV–2, including the associated 

epidemiological data and testing results. 

DATES: CDC must receive written 

comments on or before October 12, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0080 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 


jbell on DSKJLSW7X2PROD with NOTICES